PRNT and Inhibition Assays for Neutralizing Antibodies
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Washington University in St. Louis, MacroGenics (United States), New York State Department of Health, Wadsworth Center, State Farm (United States)
Protocol cited in 6 other protocols
Variable analysis
- Monoclonal antibody type (E16 or E24)
- Monoclonal antibody concentration (2.5 μg)
- Plaque reduction neutralization titer (PRNT50 and PRNT90)
- Viral titer in J774.2 mouse macrophage supernatant
- Cell lines used for PRNT (BHK21 or SW13 cells)
- Virus strain (West Nile Virus, WNV)
- Incubation time (1 h at 4 °C for PRNT, 1 h for J774.2 mouse macrophages)
- Cell numbers (5 × 10^2 PFU of WNV, 5 × 10^4 J774.2 mouse macrophages)
- Cell culture media (DMEM with 10% FBS)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!